---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-012366"
form_type: "8-K"
ticker: "IRD"
cik: "0001228627"
company_name: "Opus Genetics, Inc."
filed_at: "2025-04-04T23:59:59+00:00"
generated_at: "2026-05-23T20:43:29.840183+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Opus Genetics terminates $50M equity purchase agreement with Lincoln Park Capital

## Summary
- Terminated Purchase Agreement with Lincoln Park Capital effective April 3, 2025.
- Agreement allowed up to $50M in stock sales; company cites limited value given current market price.
- Prior to termination, issued 1.7M shares for net proceeds of ~$5.2M; remaining $44.8M facility cancelled.
- Registration obligations under the agreement survive termination for 90 days.

## SEC filing metadata
- accession: 0001140361-25-012366
- form_type: 8-K
- ticker: IRD
- cik: 0001228627
- company_name: Opus Genetics, Inc.
- filed_at: 2025-04-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1228627/000114036125012366/0001140361-25-012366-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1228627/000114036125012366/ef20046946_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-012366
- JSON: https://secwatch.observer/filing/0001140361-25-012366.json
- Plain text: https://secwatch.observer/filing/0001140361-25-012366.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.